EXHIBIT 99.1
                                                             ------------

Cautionary statement regarding forward looking statements made by the Company,
intended to have the benefit of the "safe harbor" provisions of the Private
Securities Litigation Reform Act of 1995.

The Company is hereby filing a cautionary statement identifying important
factors that could cause the Company's actual results to differ materially
from those projected in forward looking statements made by or on behalf of
the Company.  There are several communications made by or on behalf of the
Company (including the Company's Annual Report to Stockholders and Form 10-K)
which contain statements relating to goals, plans and projections regarding
its financial position, results of operations, market position and product
development, among other things, which are based on current expectations that
involve inherit risks and uncertainties including factors that would delay,
divert or change one of them in the next several years.

These important factors include --

New government laws and regulations, such as (i) health care initiatives,
(ii) changes in the FDA and foreign regulatory approval processes which
may cause delays in approving new products, (iii) tax changes such as the
phasing out of tax benefits heretofore available in the United States and
certain foreign countries.

Difficulties in developing new products; new products developed by competitors
which have lower prices or superior performance features or which are
otherwise competitive with the Company's current products; and generic
competition as the Company's products go off patent, as well as possible
problems with licensors.

Legal difficulties including negative results relating to patents; adverse
decisions in litigation including the breast implant cases and other product
liability cases; the inability to obtain adequate insurance with respect to
this type of liability; recalls of pharmaceutical products or forced closings
of manufacturing plants.

Increasing pricing pressures worldwide from managed care buyers and
institutional and governmental purchasers; the impact of Year 2000 problems;
and changes of business and economic conditions including, but not limited to,
changes in interest rates and fluctuation of foreign currency exchange rates.

No assurance can be given that any goal or plan set forth in forward looking
statements can be achieved and readers are cautioned not to place undue
reliance on such statements, which speak only as of the date made.  The
Company undertakes no obligation to release publicly any revisions to forward
looking statements as a result of future events or developments.

                              E-8-1